Stay updated on Pregnenolone in Autism Clinical Trial
Sign up to get notified when there's something new on the Pregnenolone in Autism Clinical Trial page.

Latest updates to the Pregnenolone in Autism Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov page for the pregnenolone autism trial is displayed instead of a 403 Forbidden response, with its study details, eligibility criteria, interventions, and outcomes.SummaryDifference45%

- Check13 days agoChange DetectedThe study-record page no longer displays a 403 Forbidden message, and the site revision label changes from v3.7.2 to v3.8.0. The study details themselves are not shown.SummaryDifference0.6%

- Check20 days agoChange DetectedA banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” It appears above the study page’s 403 error message.SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedUsers attempting to view the study record are now shown a 403 Forbidden page, blocking access to the trial details and related content. This indicates an access issue on the site affecting essential page content delivery.SummaryDifference17%

Stay in the know with updates to Pregnenolone in Autism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pregnenolone in Autism Clinical Trial page.